Cantor Sees 'Blockbuster Potential' In Aerie Pharma's (AERI) Rocklatan Script Data
Tweet Send to a Friend
Cantor Fitzgerald analyst Elemer Piros reiterated an Overweight rating and $85.00 price target on Aerie Pharma (NASDAQ: AERI) after seeing ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
